December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreOctober 10, 2025
Projections indicate that, North America central lab industry is projected to rise from USD 1384 million in 2024 to USD 2411 million by 2034, reflecting a CAGR of 5.71% over the next decade. The presence of a favorable clinical trial infrastructure and regulatory support drives the market. The dominance of the U.S. is attributed to the presence of ...
October 09, 2025
According to market projections, the global hematology analyzers market, valued at USD 4.08 billion in 2024, is anticipated to reach USD 7.28 billion by 2034, growing at a CAGR of 5.97% over the next decade. Majorly impacting factors like rising prevalence of blood disorders such as anaemia, thalassemia, leukemia, and progressing innovations in pha...
October 09, 2025
Projections indicate that, Middle East & Africa behavioral health industry is projected to rise from USD 5.2 billion in 2024 to USD 9.99 billion by 2034, reflecting a CAGR of 6.75% over the next decade. The rising prevalence of mental health disorders and technological advancements drive the market. GCC countries dominated due to the increasing...
October 09, 2025
Market insights predict the global North America biotechnology industry will increase from USD 635.89 billion in 2024 to USD 1813.13 billion by 2034, achieving a CAGR of 11.80%. The increasing adoption of advanced technologies and rising investments bolster market growth. The United States dominated due to the strong presence of key players and fav...
October 09, 2025
Market insights predict, the Latin America cell and gene therapy industry is expected to grow from USD 1.15 billion in 2024 to USD 10.19 billion by 2034, driven by a CAGR of 24.40%. The rising prevalence of chronic and genetic diseases is expected to drive the growth of the market....
October 09, 2025
Market insights predict, the Europe central lab industry is expected to grow from USD 865 million in 2024 to USD 1507 million by 2034, driven by a CAGR of 5.71%. The market is growing due to rising clinical trial volumes, precision medicine adoption, and increased outsourcing by pharmaceutical companies. Western Europe dominates the market ow...
October 09, 2025
According to market projections, the global APAC central lab market, valued at USD 622 million in 2024, is anticipated to reach USD 1085 million by 2034, growing at a CAGR of 5.72% over the next decade. The market is expanding as pharmaceutical and biotech companies increasingly rely on specialized labs for accurate, efficient, and standardized tes...
October 08, 2025
Projections indicate that, the global generative AI in drug discovery market will increase from USD 250 million in 2024 to USD 2847.43 million by 2034, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery market is growing rapidly due to technological advancements and rising government initiatives to develop nov...
October 08, 2025
Based on market forecasts, the mRNA therapeutics CDMO sector will expand from USD 4.62 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 11.37%.The growing demand for vaccines and the rising prevalence of chronic disorders drive the market. The availability of state-of-the-art research and development facilities and increasing go...
October 08, 2025
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the market. The availability of a robust healthcare infrastructure and favorable reimbursement policies ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com